Our study showed that even at the 5-year the detection rate of PCa was 1.0%, 5.8% and 9.6% in patients with baseline PSA 0.01–4.00 ng/ml, 4.01–10.00 ng/ml and >10.00 ng/ml, respectively. This evidence concerns the gene KLK3 and posterior cortical atrophy.